Health
Pfizer to submit emergence use approval request for Covid-19 vaccine again: Spokesperson – Deccan Herald
After reports of Pfizer withdrawing its application for emergency use authorisation of its Covid-19 vaccine in India, the company spokesperson said that it will resubmit…
Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its Covid-19 vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study.
The decision means the vaccine will not be available for sale in the world’s two most populous countries, India and China, in the near future. Both countries are running their immunisation campaigns using other products.
Unlike other companies conducting small studies in India for…
-
General10 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
Business18 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News22 hours agoResilience features in Sunshine Coast Open House
-
Noosa News16 hours agoPerth Royal Show vendors upset by price hikes, say crowds are down in 2025